The store will not work correctly when cookies are disabled.
2-(6-Chloro-pyridin-3-yl)-9-aza-bicyclo[4.2.1]non-2-ene (UB-165)
ID: ALA275466
PubChem CID: 44266835
Max Phase: Preclinical
Molecular Formula: C13H15ClN2
Molecular Weight: 234.73
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Clc1ccc(C2=CCC[C@H]3CCC2N3)cn1
Standard InChI: InChI=1S/C13H15ClN2/c14-13-7-4-9(8-15-13)11-3-1-2-10-5-6-12(11)16-10/h3-4,7-8,10,12,16H,1-2,5-6H2/t10-,12?/m0/s1
Standard InChI Key: TVSNVPGPFGAKPT-NUHJPDEHSA-N
Molfile:
RDKit 2D
17 19 0 0 1 0 0 0 0 0999 V2000
9.2750 -3.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6167 -2.7792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7500 -3.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3500 -1.9167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4750 -2.8167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8750 -1.8500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6417 -3.6750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1542 -2.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2125 -3.5875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9917 -2.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5167 -3.8750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1917 -2.2667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0750 -1.3667 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
7.9875 -4.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5000 -4.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9792 -4.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4497 -4.8728 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 1 1 0
4 8 2 0
5 1 1 0
6 12 2 0
7 1 2 0
8 5 1 0
9 3 1 0
10 5 2 0
11 2 1 0
12 10 1 0
13 6 1 0
14 9 1 0
15 7 1 0
15 16 1 0
11 16 1 0
11 14 1 0
6 4 1 0
11 17 1 6
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 234.73 | Molecular Weight (Monoisotopic): 234.0924 | AlogP: 3.03 | #Rotatable Bonds: 1 |
Polar Surface Area: 24.92 | Molecular Species: BASE | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.25 | CX LogP: 2.54 | CX LogD: -0.16 |
Aromatic Rings: 1 | Heavy Atoms: 16 | QED Weighted: 0.76 | Np Likeness Score: 0.72 |
References
1. Gohlke H, Gündisch D, Schwarz S, Seitz G, Tilotta MC, Wegge T.. (2002) Synthesis and nicotinic binding studies on enantiopure diazine analogues of the novel (2-chloro-5-pyridyl)-9-azabicyclo[4.2.1]non-2-ene UB-165., 45 (5): [PMID:11855986] [10.1021/jm010936y] |
2. Sharples CG, Karig G, Simpson GL, Spencer JA, Wright E, Millar NS, Wonnacott S, Gallagher T.. (2002) Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165., 45 (15): [PMID:12109907] [10.1021/jm020814l] |
3. Jensen AA, Frølund B, Liljefors T, Krogsgaard-Larsen P.. (2005) Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations., 48 (15): [PMID:16033252] [10.1021/jm040219e] |